Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Otto

Showing results (531-540 of 558) with videos related to

Pageof 56
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938P Ganapati Reddy, Donghui Bao, Wonsuk Chang, et al.
ESMO Open|March 1, 2022
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU studyN Girard, S Galland-Girodet, V Avrillon, et al.
Science (New York, N.Y.)|January 12, 2013
Strong, light, multifunctional fibers of carbon nanotubes with ultrahigh conductivityNatnael Behabtu, Colin C Young, Dmitri E Tsentalovich, et al.
Journal of Shoulder and Elbow Surgery|January 23, 2022
A validated algorithm using current literature to judge the appropriateness of anatomic total shoulder arthroplasty utilizing the RAND/UCLA appropriateness methodStephen Le Breton, Stephen Sylvia, Sundeep Saini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trialD Moro-Sibilot, N Cozic, M Pérol, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replicationAngela M Lam, Eisuke Murakami, Christine Espiritu, et al.
Chemistry & Biology|April 1, 1996
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450C N Hodge, P E Aldrich, L T Bacheler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Vemurafenib in non-small-cell lung cancer patients with BRAF<sup>V600</sup> and BRAF<sup>nonV600</sup> mutationsJ Mazieres, C Cropet, L Montané, et al.
Cancers|October 23, 2021
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence VariantsAmol Prakash, Lorne Taylor, Manu Varkey, et al.
The New England Journal of Medicine|August 17, 2012
Quality-of-life effects of prostate-specific antigen screeningEveline A M Heijnsdijk, Elisabeth M Wever, Anssi Auvinen, et al.
Pageof 56

Showing results (531-540 of 558) with videos related to

Sort By:
Pageof 56
Bioorganic & Medicinal Chemistry Letters|November 6, 2010
2'-deoxy-2'-α-fluoro-2'-β-C-methyl 3',5'-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: discovery of PSI-352938P Ganapati Reddy, Donghui Bao, Wonsuk Chang, et al.
ESMO Open|March 1, 2022
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU studyN Girard, S Galland-Girodet, V Avrillon, et al.
Science (New York, N.Y.)|January 12, 2013
Strong, light, multifunctional fibers of carbon nanotubes with ultrahigh conductivityNatnael Behabtu, Colin C Young, Dmitri E Tsentalovich, et al.
Journal of Shoulder and Elbow Surgery|January 23, 2022
A validated algorithm using current literature to judge the appropriateness of anatomic total shoulder arthroplasty utilizing the RAND/UCLA appropriateness methodStephen Le Breton, Stephen Sylvia, Sundeep Saini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2019
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trialD Moro-Sibilot, N Cozic, M Pérol, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2010
PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replicationAngela M Lam, Eisuke Murakami, Christine Espiritu, et al.
Chemistry & Biology|April 1, 1996
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450C N Hodge, P E Aldrich, L T Bacheler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Vemurafenib in non-small-cell lung cancer patients with BRAF<sup>V600</sup> and BRAF<sup>nonV600</sup> mutationsJ Mazieres, C Cropet, L Montané, et al.
Cancers|October 23, 2021
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence VariantsAmol Prakash, Lorne Taylor, Manu Varkey, et al.
The New England Journal of Medicine|August 17, 2012
Quality-of-life effects of prostate-specific antigen screeningEveline A M Heijnsdijk, Elisabeth M Wever, Anssi Auvinen, et al.
Pageof 56